We are live on
!
Find out more
WCM
Whitefort Capital Management Portfolio holdings
AUM
$339M
1-Year Est. Return
52.48%
This Fund
S&P 500
This Quarter
Est. Return
+12.84%
1 Year Est. Return
+52.48%
3 Year Est. Return
+179.31%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$209M
AUM Growth
-$10.7M
(-4.8%)
Cap. Flow
-$42.9M
Cap. Flow
% of AUM
-20.51%
Top 10 Holdings %
Top 10 Hldgs %
92.87%
Holding
19
New
1
Increased
3
Reduced
5
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cadiz
CDZI
|
+$13.4M |
| 2 |
Liquidia Corp
LQDA
|
+$3.12M |
| 3 |
Arbutus Biopharma
ABUS
|
+$1.38M |
| 4 |
Global Ship Lease
GSL
|
+$69.9K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$14.9M |
| 2 |
Core Scientific
CORZ
|
+$13.6M |
| 3 |
NextNav
NN
|
+$8.3M |
| 4 |
JOYY
JOYY Inc
JOYY
|
+$5.34M |
| 5 |
NNAVW
NextNav Inc Warrant
NNAVW
|
+$1.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 45.57% |
| 2 | Communication Services | 15.91% |
| 3 | Financials | 11.61% |
| 4 | Utilities | 9.26% |
| 5 | Technology | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Arbutus Biopharma
ABUS
$865M
| $43.3M | 20.72% |
13,241,916
+373,949
| +3% | +$1.38M |
|
2
Roivant Sciences
ROIV
$25.2B
| $28.3M | 13.54% |
2,391,000
| – | – |
|
|
3
Liquidia Corp
LQDA
$7.67B
| $23.4M | 11.18% |
1,987,245
+285,220
| +17% | +$3.12M |
|
4
Genworth Financial
GNW
$3.8B
| $20.9M | 9.99% |
2,986,960
| – | – |
|
|
5
Cadiz
CDZI
$266M
| $19.3M | 9.26% |
+3,719,951
| New | +$13.4M |
|
|
JOYY
6
JOYY Inc
JOYY
$3.73B
| $17.6M | 8.42% |
420,427
-145,451
| -26% | -$5.34M |
|
|
EDR
7
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $15.6M | 7.49% |
500,000
-500,000
| -50% | -$14.9M |
|
|
8
NextNav
NN
$1.7B
| $9.8M | 4.69% |
629,590
-623,241
| -50% | -$8.3M |
|
|
9
Global Ship Lease
GSL
$1.57B
| $8.07M | 3.86% |
369,768
+2,997
| +0.8% | +$69.9K |
|
|
KG
10
Kestrel Group
KG
$71.3M
| $3.37M | 1.62% |
99,850
-2,558
| -2% | -$81.8K |
|
11
INNOVATE Corp
VATE
$114M
| $1.58M | 0.76% |
320,131
| – | – |
|
|
NNAVW
12
DELISTED
NextNav Inc Warrant
NNAVW
| $579K | 0.28% |
100,880
-382,071
| -79% | -$1.95M |
|
13
Opko Health
OPK
$921M
| $198K | 0.09% |
134,490
| – | – |
|
|
TRIB
14
Trinity Biotech
TRIB
$5.7M
| $72.1K | 0.03% |
2,730
| – | – |
|
|
AEAEW
15
DELISTED
AltEnergy Acquisition Corp Warrant
AEAEW
| $783 | ﹤0.01% |
186,315
| – | – |
|
|
16
Core Scientific
CORZ
$7.23B
| – | – |
-1,147,500
| Closed | -$13.6M |
|
Similar funds
BAM
VCM
PB
SCM
CAC
JCIA
CWM
MP
Whitefort Capital Management's Q4 2024 Portfolio in Review
As of Q4 2024, Whitefort Capital Management held 19 positions worth $209M, down 4.8% from $220M the previous quarter. Its ten largest holdings account for 93% of the portfolio.
Whitefort Capital Management withdrew a net $42.9M in Q4 2024, closing 1 position and reducing 5 holdings. Its most notable exit was Core Scientific, an estimated $13.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 43% a quarter earlier, followed by Communication Services and Financials.
Against the trend, Whitefort Capital Management opened a new position in Cadiz worth $19.3M.
- Whitefort Capital Management's largest Q4 2024 buy was Cadiz: 3,719,951 shares worth $19.3M.
- Whitefort Capital Management added most to Liquidia Corp in Q4 2024, an estimated $3.12M increase.
- Whitefort Capital Management's biggest Q4 2024 reduction was Endeavor Group Holdings, Inc., cutting an estimated $14.9M.
- Whitefort Capital Management fully exited Core Scientific in Q4 2024, selling an estimated $13.6M.
- Whitefort Capital Management's ten largest holdings make up 93% of its $209M portfolio in Q4 2024.
- Whitefort Capital Management opened 1 new position and closed 1 in Q4 2024.
- Whitefort Capital Management's portfolio value fell 4.8% quarter-over-quarter to $209M.
Based on Whitefort Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.